AB
RLAY icon

Amalgamated Bank’s Relay Therapeutics RLAY Stock Holding History

Amalgamated Bank’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,424
Closed -$37K – 2568
2025
Q4 		$37K Buy
4,424
+224
+5% +$1.6K ﹤0.01% 1910
2025
Q3 		$22K Hold
4,200
– – ﹤0.01% 2082
2025
Q2 		$15K Hold
4,200
– – ﹤0.01% 2246
2025
Q1 		$11K Buy
4,200
+845
+25% +$3.31K ﹤0.01% 2340
2024
Q4 		$14K Hold
3,355
– – ﹤0.01% 2291
2024
Q3 		$24K Hold
3,355
– – ﹤0.01% 2062
2024
Q2 		$22K Buy
3,355
+283
+9% +$1.93K ﹤0.01% 2085
2024
Q1 		$25K Sell
3,072
-5,129
-63% -$50K ﹤0.01% 2052
2023
Q4 		$90K Sell
8,201
-914
-10% -$7.71K ﹤0.01% 2037
2023
Q3 		$77K Buy
9,115
+558
+7% +$6K ﹤0.01% 2091
2023
Q2 		$107K Sell
8,557
-651
-7% -$8.1K ﹤0.01% 2038
2023
Q1 		$152K Sell
9,208
-2,114
-19% -$37.9K ﹤0.01% 1904
2022
Q4 		$169K Buy
11,322
+1,336
+13% +$25.6K ﹤0.01% 1923
2022
Q3 		$223K Buy
9,986
+102
+1% +$2.24K ﹤0.01% 1808
2022
Q2 		$166K Sell
9,884
-1,203
-11% -$25.8K ﹤0.01% 1959
2022
Q1 		$332K Sell
11,087
-828
-7% -$20.1K ﹤0.01% 1724
2021
Q4 		$366K Buy
11,915
+1,554
+15% +$49.1K ﹤0.01% 1727
2021
Q3 		$327K Sell
10,361
-388
-4% -$13.1K ﹤0.01% 1807
2021
Q2 		$393K Buy
10,749
+4,867
+83% +$160K ﹤0.01% 1766
2021
Q1 		$203K Buy
+5,882
New +$255K 0.01% 1480

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Amalgamated Bank's RLAY Position: Q1 2026 in Review

Amalgamated Bank sold out of Relay Therapeutics (RLAY) in Q1 2026, closing a stake of 4,424 shares — an estimated $37K sold.

Amalgamated Bank first reported a position in RLAY in Q1 2021 and held it in 20 quarters. The position peaked at $393K in Q2 2021. 243 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Amalgamated Bank reported no remaining Relay Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 4,424 Relay Therapeutics shares in Q1 2026, an estimated $37K.
  • Amalgamated Bank first reported a position in Relay Therapeutics in Q1 2021 and held it in 20 quarters.
  • Amalgamated Bank's Relay Therapeutics position peaked at $393K in Q2 2021.
  • 243 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.